Avance Clinical, a leading full-service global Contract Research Organization (CRO), has announced the signing of three pivotal Memorandums of Understanding (MOUs) with prominent clinical sites in South Korea during the KoNECT 2024 conference. This milestone marks a key step in Avance Clinical’s strategy to expand its high-quality, agile clinical research services across the Asia-Pacific region.

Avance Clinical’s CEO Yvonne Lungershausen and Asia Regional Director Jessica Han represented the company at KoNECT, formalizing partnerships with CHA University Bundang Medical Center, Korea University Medicine, and Dong-A University Hospital. "These new MOUs further strengthen our mission to provide world-class services to international biotech clients," stated Lungershausen. "As Avance Clinical grows its global footprint, these partnerships will enhance our ability to offer flexible and efficient clinical trial services in Asia."

Jessica Han added, “With South Korea’s advanced healthcare infrastructure, these partnerships will not only solidify our collaborations but also provide seamless access to high-quality trial sites and patient populations for our clients."

The MOUs include collaborations with:

• CHA University Bundang Medical Center, focused on patient care, research, and education, and committed to delivering a stable research environment. Young-Sang Kim, Director of CHA Global Clinical Trials Center, remarked, "This partnership expands our clinical trial expertise, especially in early-phase research."

• Korea University Medicine (Seoul), a leader in clinical trials, aiming to accelerate clinical research opportunities with Avance Clinical. Hak Jun Kim, President of Medical Research & Business Foundation at Korea University Medicine, noted, "This MOU is an important step in advancing our shared goals in clinical trial excellence."

• Dong-A University Hospital, Clinical Trial Center (Pusan), known for its robust research teams and infrastructure, to advance early-phase clinical trials. Director Sung Yong Oh expressed, "By working together, we enhance our research infrastructure and accelerate innovations in global healthcare."

These collaborations reflect Avance Clinical’s commitment to expanding its Asia-Pacific footprint and advancing therapeutic research across regions. KoNECT 2024, co-hosted by the Korea National Enterprise for Clinical Trials (KoNECT) and the Ministry of Health and Welfare (MOHW), brought together global thought leaders to discuss innovations shaping the future of clinical trials.